Efficient Performance Of The Sartoflow® Expert SU In ADC Processes
In the biopharmaceutical industry, antibody-drug conjugates (ADCs) represent a significant area of growth. Today, downstream processing steps are typically carried out as individual unit operations. However, manufacturers require more integrated solutions to increase the robustness of their ADC processes.
Explore the capabilities of a fully automated, single-use (SU) tangential flow filtration (TFF) system that can be configured to perform the incubation, purification, and concentration steps of ADC synthesis.
VIEW THE APPLICATION NOTE! Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X
Enter your credentials below to log in. Not yet a member of Drug Discovery Online? Subscribe today.
Subscribe to Drug Discovery Online X
Subscribe to Drug Discovery Online